Modify putative N-glycosylation web sites by means of asparagine (N)-toglutamine (Q) mutations, an
Modify putative N-glycosylation websites by way of asparagine (N)-toglutamine (Q) mutations, an strategy utilized previously in protein vaccine development.21-24 The immunogenic properties of the yeast-expressed, engineered LdNH36 (LdNH36-dg2) were evaluated…